Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 39,437Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Dr. Reddy's Laboratories

02 1Alembic Pharmaceuticals Limited

03 1Amneal Pharmaceuticals

04 1GLAND PHARMA LIMITED

05 1MSN Laboratories

06 1Meitheal Pharmaceuticals

07 1Nexus Pharmaceuticals

08 5Sandoz B2B

09 2Shorla Oncology

10 2Tobio Novelfarma

11 1XGen Pharmaceuticals

12 1Zydus Pharmaceuticals

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : RX

Registration Country : USA

NELARABINE

Brand Name : NELARABINE

Dosage Form : INJECTABLE;INTRAVENOUS

Dosage Strength : 250MG/50ML (5MG/ML)

Packaging :

Approval Date : 2022-12-23

Application Number : 216934

Regulatory Info : RX

Registration Country : USA

Dr Reddy Company Banner

02

ISPE Annual Meeting
Not Confirmed
arrow
arrow
ISPE Annual Meeting
Not Confirmed

NELARABINE

Brand Name : NELARABINE

Dosage Form : INJECTABLE;INTRAVENOUS

Dosage Strength : 250MG/50ML (5MG/ML)

Packaging :

Approval Date : 2024-08-01

Application Number : 218554

Regulatory Info : RX

Registration Country : USA

blank

03

ISPE Annual Meeting
Not Confirmed
arrow
arrow
ISPE Annual Meeting
Not Confirmed

NELARABINE

Brand Name : NELARABINE

Dosage Form : INJECTABLE;INTRAVENOUS

Dosage Strength : 250MG/50ML (5MG/ML)

Packaging :

Approval Date : 2023-04-04

Application Number : 216346

Regulatory Info : RX

Registration Country : USA

blank

04

ISPE Annual Meeting
Not Confirmed
arrow
arrow
ISPE Annual Meeting
Not Confirmed

NELARABINE

Brand Name : NELARABINE

Dosage Form : INJECTABLE;INTRAVENOUS

Dosage Strength : 250MG/50ML (5MG/ML)

Packaging :

Approval Date : 2024-01-03

Application Number : 212605

Regulatory Info : RX

Registration Country : USA

blank

05

ISPE Annual Meeting
Not Confirmed
arrow
arrow
ISPE Annual Meeting
Not Confirmed

NELARABINE

Brand Name : NELARABINE

Dosage Form : INJECTABLE;INTRAVENOUS

Dosage Strength : 250MG/50ML (5MG/ML)

Packaging :

Approval Date : 2023-01-10

Application Number : 216038

Regulatory Info : RX

Registration Country : USA

blank

06

ISPE Annual Meeting
Not Confirmed
arrow
arrow
ISPE Annual Meeting
Not Confirmed

NELARABINE

Brand Name : NELARABINE

Dosage Form : INJECTABLE;INTRAVENOUS

Dosage Strength : 250MG/50ML (5MG/ML)

Packaging :

Approval Date : 2024-09-13

Application Number : 216948

Regulatory Info : RX

Registration Country : USA

blank

07

ISPE Annual Meeting
Not Confirmed
arrow
arrow
ISPE Annual Meeting
Not Confirmed

NELARABINE

Brand Name : NELARABINE

Dosage Form : INJECTABLE;INTRAVENOUS

Dosage Strength : 250MG/50ML (5MG/ML)

Packaging :

Approval Date : 2023-06-02

Application Number : 215057

Regulatory Info : RX

Registration Country : USA

blank

08

ISPE Annual Meeting
Not Confirmed
arrow
arrow
ISPE Annual Meeting
Not Confirmed

NELARABINE

Brand Name : ARRANON

Dosage Form : INJECTABLE;INTRAVENOUS

Dosage Strength : 250MG/50ML (5MG/ML)

Packaging :

Approval Date : 2005-10-28

Application Number : 21877

Regulatory Info : RX

Registration Country : USA

blank

09

ISPE Annual Meeting
Not Confirmed
arrow
arrow
ISPE Annual Meeting
Not Confirmed

Nelarabin

Brand Name : Atriance

Dosage Form : Infusion Solution

Dosage Strength : 5mg/ml

Packaging :

Approval Date : 22/08/2007

Application Number : 20061121000045

Regulatory Info : Approved

Registration Country : Sweden

blank

10

ISPE Annual Meeting
Not Confirmed
arrow
arrow
ISPE Annual Meeting
Not Confirmed

Non-Arabic

Brand Name : Atriance

Dosage Form : Infusion Solution

Dosage Strength : 250mg/50ml

Packaging :

Approval Date : 08/08/2007

Application Number : 57899

Regulatory Info : Allowed

Registration Country : Switzerland

blank

11

ISPE Annual Meeting
Not Confirmed
arrow
arrow
ISPE Annual Meeting
Not Confirmed

NELARABINE

Brand Name : ATRIANCE

Dosage Form : SOLUTION

Dosage Strength : 5MG/ML

Packaging : 6X50ML

Approval Date :

Application Number : 2299925

Regulatory Info : Prescription

Registration Country : Canada

blank

12

ISPE Annual Meeting
Not Confirmed
arrow
arrow
ISPE Annual Meeting
Not Confirmed

Nelarabine

Brand Name : Atriance

Dosage Form : Solution For Perfusion

Dosage Strength : 5MG

Packaging :

Approval Date : 2007-09-18

Application Number : 07403001

Regulatory Info : Authorized

Registration Country : Spain

blank

13

ISPE Annual Meeting
Not Confirmed
arrow
arrow
ISPE Annual Meeting
Not Confirmed

NELARABINE

Brand Name : NELARABINE

Dosage Form : INJECTABLE;INTRAVENOUS

Dosage Strength : 250MG/50ML (5MG/ML)

Packaging :

Approval Date : 2023-03-03

Application Number : 214809

Regulatory Info : RX

Registration Country : USA

blank

14

ISPE Annual Meeting
Not Confirmed
arrow
arrow
ISPE Annual Meeting
Not Confirmed

NELARABINE

Brand Name : NELARABINE

Dosage Form : INJECTABLE;INTRAVENOUS

Dosage Strength : 375MG/75ML (5MG/ML)

Packaging :

Approval Date : 2025-07-16

Application Number : 214809

Regulatory Info : RX

Registration Country : USA

blank

15

ISPE Annual Meeting
Not Confirmed
arrow
arrow
ISPE Annual Meeting
Not Confirmed

Nelarabine

Brand Name : ACYTANE

Dosage Form : Solution for Infusion

Dosage Strength : 250MG/50 ML VIAL

Packaging : 6 Vials/ Box

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Turkey

blank

16

ISPE Annual Meeting
Not Confirmed
arrow
arrow
ISPE Annual Meeting
Not Confirmed

Nelarabine

Brand Name : ACYTANE

Dosage Form : Solution for Infusion

Dosage Strength : 250MG/50 ML VIAL

Packaging : 6 Vials/ Box

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Turkey

blank

17

ISPE Annual Meeting
Not Confirmed
arrow
arrow
ISPE Annual Meeting
Not Confirmed

NELARABINE

Brand Name : NELARABINE

Dosage Form : INJECTABLE;INTRAVENOUS

Dosage Strength : 250MG/50ML (5MG/ML)

Packaging :

Approval Date : 2024-09-05

Application Number : 216510

Regulatory Info : RX

Registration Country : USA

blank

18

ISPE Annual Meeting
Not Confirmed
arrow
arrow
ISPE Annual Meeting
Not Confirmed

NELARABINE

Brand Name : NELARABINE

Dosage Form : INJECTABLE;INTRAVENOUS

Dosage Strength : 250MG/50ML (5MG/ML)

Packaging :

Approval Date : 2021-11-17

Application Number : 215037

Regulatory Info : RX

Registration Country : USA

blank